More importantly, IFN‐β treatment in a multiple sclerosis patient completely reversed subfoveal neovascularization and choroiditis emphasizing the therapeutic potential of IFN‐β for inflammatory and vascular diseases of the eye (Cirino et al,2006). This evidence concerns the gene IFNB1 and eye neoplasm.